Cargando…
The Development and Clinical Applications of Oral Arsenic Trioxide for Acute Promyelocytic Leukaemia and Other Diseases
Appreciation of the properties of arsenic trioxide (ATO) has redefined the treatment landscape for acute promyelocytic leukaemia (APL) and offers promise as a treatment for numerous other diseases. The benefits of ATO in patients with APL is related to its ability to counteract the effects of PML::R...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504237/ https://www.ncbi.nlm.nih.gov/pubmed/36145693 http://dx.doi.org/10.3390/pharmaceutics14091945 |
_version_ | 1784796165487722496 |
---|---|
author | Chin, Lynn Kumana, Cyrus R. Kwong, Yok-Lam Gill, Harinder |
author_facet | Chin, Lynn Kumana, Cyrus R. Kwong, Yok-Lam Gill, Harinder |
author_sort | Chin, Lynn |
collection | PubMed |
description | Appreciation of the properties of arsenic trioxide (ATO) has redefined the treatment landscape for acute promyelocytic leukaemia (APL) and offers promise as a treatment for numerous other diseases. The benefits of ATO in patients with APL is related to its ability to counteract the effects of PML::RARA, an oncoprotein that is invariably detected in the blood or bone marrow of affected individuals. The PML::RARA oncoprotein is degraded specifically by binding to ATO. Thus ATO, in combination with all-trans retinoic acid, has become the curative treatment for ATO. The multiple mechanisms of action of ATO has also paved the way for application in various condition encompassing autoimmune or inflammatory disorders, solid organ tumours, lymphomas and other subtypes of AML. The development of oral formulation of ATO (oral ATO) has reduced costs of treatment and improved treatment convenience allowing widespread applicability. In this review, we discuss the mechanisms of action of ATO, the development of oral ATO, and the applications of oral ATO in APL and other diseases. |
format | Online Article Text |
id | pubmed-9504237 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95042372022-09-24 The Development and Clinical Applications of Oral Arsenic Trioxide for Acute Promyelocytic Leukaemia and Other Diseases Chin, Lynn Kumana, Cyrus R. Kwong, Yok-Lam Gill, Harinder Pharmaceutics Review Appreciation of the properties of arsenic trioxide (ATO) has redefined the treatment landscape for acute promyelocytic leukaemia (APL) and offers promise as a treatment for numerous other diseases. The benefits of ATO in patients with APL is related to its ability to counteract the effects of PML::RARA, an oncoprotein that is invariably detected in the blood or bone marrow of affected individuals. The PML::RARA oncoprotein is degraded specifically by binding to ATO. Thus ATO, in combination with all-trans retinoic acid, has become the curative treatment for ATO. The multiple mechanisms of action of ATO has also paved the way for application in various condition encompassing autoimmune or inflammatory disorders, solid organ tumours, lymphomas and other subtypes of AML. The development of oral formulation of ATO (oral ATO) has reduced costs of treatment and improved treatment convenience allowing widespread applicability. In this review, we discuss the mechanisms of action of ATO, the development of oral ATO, and the applications of oral ATO in APL and other diseases. MDPI 2022-09-14 /pmc/articles/PMC9504237/ /pubmed/36145693 http://dx.doi.org/10.3390/pharmaceutics14091945 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Chin, Lynn Kumana, Cyrus R. Kwong, Yok-Lam Gill, Harinder The Development and Clinical Applications of Oral Arsenic Trioxide for Acute Promyelocytic Leukaemia and Other Diseases |
title | The Development and Clinical Applications of Oral Arsenic Trioxide for Acute Promyelocytic Leukaemia and Other Diseases |
title_full | The Development and Clinical Applications of Oral Arsenic Trioxide for Acute Promyelocytic Leukaemia and Other Diseases |
title_fullStr | The Development and Clinical Applications of Oral Arsenic Trioxide for Acute Promyelocytic Leukaemia and Other Diseases |
title_full_unstemmed | The Development and Clinical Applications of Oral Arsenic Trioxide for Acute Promyelocytic Leukaemia and Other Diseases |
title_short | The Development and Clinical Applications of Oral Arsenic Trioxide for Acute Promyelocytic Leukaemia and Other Diseases |
title_sort | development and clinical applications of oral arsenic trioxide for acute promyelocytic leukaemia and other diseases |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504237/ https://www.ncbi.nlm.nih.gov/pubmed/36145693 http://dx.doi.org/10.3390/pharmaceutics14091945 |
work_keys_str_mv | AT chinlynn thedevelopmentandclinicalapplicationsoforalarsenictrioxideforacutepromyelocyticleukaemiaandotherdiseases AT kumanacyrusr thedevelopmentandclinicalapplicationsoforalarsenictrioxideforacutepromyelocyticleukaemiaandotherdiseases AT kwongyoklam thedevelopmentandclinicalapplicationsoforalarsenictrioxideforacutepromyelocyticleukaemiaandotherdiseases AT gillharinder thedevelopmentandclinicalapplicationsoforalarsenictrioxideforacutepromyelocyticleukaemiaandotherdiseases AT chinlynn developmentandclinicalapplicationsoforalarsenictrioxideforacutepromyelocyticleukaemiaandotherdiseases AT kumanacyrusr developmentandclinicalapplicationsoforalarsenictrioxideforacutepromyelocyticleukaemiaandotherdiseases AT kwongyoklam developmentandclinicalapplicationsoforalarsenictrioxideforacutepromyelocyticleukaemiaandotherdiseases AT gillharinder developmentandclinicalapplicationsoforalarsenictrioxideforacutepromyelocyticleukaemiaandotherdiseases |